Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome

We aimed to evaluate the effect of baseline low-density lipoprotein cholesterol (LDL-C) on the outcomes of patients with the acute coronary syndrome (ACS) receiving pitavastatin monotherapy or the combination of pitavastatin + ezetimibe. In the HIJ-PROPER study, 1734 ACS patients with dyslipidemia w...

Descripción completa

Detalles Bibliográficos
Autores principales: Im, Jihaeng, Kawada-Watanabe, Erisa, Yamaguchi, Junichi, Arashi, Hiroyuki, Otsuki, Hisao, Matsui, Yuko, Sekiguchi, Haruki, Fujii, Shinya, Mori, Fumiaki, Ogawa, Hiroshi, Hagiwara, Nobuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021554/
https://www.ncbi.nlm.nih.gov/pubmed/33820931
http://dx.doi.org/10.1038/s41598-021-87098-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021554/
https://www.ncbi.nlm.nih.gov/pubmed/33820931
http://dx.doi.org/10.1038/s41598-021-87098-x

Ejemplares similares